TY  - JOUR 
AU  - Hermans, Sjoerd J. F.
AU  - Versluis, Jurjen
AU  - van Werkhoven, Erik D.
AU  - van Norden, Yvette
AU  - Janssen, Jeroen J. W. M.
AU  - Huls, Gerwin A.
AU  - Pabst, Thomas
AU  - Breems, Dimitri A.
AU  - Berkx, Elizabeth
AU  - Dinmohamed, Avinash G.
AU  - Huijgens, Peter C.
AU  - Sträng, Eric
AU  - Hernández Rivas, Jesús María
AU  - Sobas, Marta
AU  - Ayala Diaz, Rosa
AU  - Martínez López, Joaquín
AU  - Metzeler, Klaus H.
AU  - Haferlach, Torsten
AU  - Thiede, Christian
AU  - Uyl-de Groot, Carin A.
AU  - Bullinger, Lars
AU  - Löwenberg, Bob
AU  - Ossenkoppele, Gert J.
AU  - Pignatti, Francesco
AU  - Cornelissen, Jan J.
PY  - 2026
UR  - http://hdl.handle.net/10366/172037
AB  - [EN]Real-world data (RWD) previously contributed to post-marketing regulatory decision-making, but are currently also considered as external controls to single-arm trials. The use of RWD control data may be compromised by methodological issues, urging...
LA  - eng
PB  - Wiley
KW  - Leukemia, Myeloid, Acute
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Humans
KW  - Aged
KW  - Male
KW  - Female
KW  - Aged, 80 and over
KW  - Prospective Studies
KW  - Registries
KW  - Aged, 80 and over
KW  - Aged
KW  - Prospective Studies
KW  - Leukemia, Myeloid, Acute
KW  - Humans
KW  - Registries
KW  - Antineoplastic Combined Chemotherapy Protocols
TI  - Comparability of external and internal control patients for the prospective randomized HOVON-103 trial in older AML patients
DO  - 10.1111/bjh.20185
T2  - British journal of haematology
VL  - 208
M2  - 179
ER  -